Piramal Life Sciences Q3FY11 revenue was at Rs 14 crore versus Rs 1.22 crore, YoY.
Its EBITDA loss was Rs 12.3 crore versus Rs 27 crore, YoY.
The company's net loss was Rs 25.6 crore versus Rs 36.7 crore, YoY.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment